The Italian drug AGENCY (Aifa) approved the reimbursement of a new therapy for the treatment of psoriasis , on plaques, moderate to severe in adult patients. It is risankizumab, a treatment that can be administered by two subcutaneous injections every 12 weeks, after two doses of the boot administered at week 0 and week 4. Once every three months, The European Commission had approved risankizumab in the month of April 2019, thanks to the results of four major clinical studies, which have evaluated more than 2 thousand patients with plaque psoriasis moderate to severe. “The redeemability in Italy risankizumab represents a further important step forward for the scientific community,” says Ketty Peris , president of Sidemast, the Italian Society of Dermatology medical, surgical, aesthetic and sexually transmitted diseases. “Today we have a new therapeutic option that can help you achieve and maintain a remission of the psoriatic plaques in a high percentage of patients. In addition, the drug has been shown to be able to maintain the clinical benefits by means of once every three months”.
clean Skin and long-lasting results “The main benefit of this drug is the level of ‘clean skin’ higher than the current standard of care,” says Francesco Cusano , president of Adoi, Association of Dermatologists Italian Hospital. “More than 80% of patients get a skin almost or completely clean even after the first dosing, and the results are maintained over time, with a safety profile very high. These data emphasize the significant improvement in the quality of care that this new treatment option may provide adults with plaque psoriasis”.
A disease of the body, which devastates the mind, psoriasis is a chronic autoimmune that affects approximately 125 million people worldwide, including 1.1 million in Italy: many patients do not reach still therapeutic goals, or observe a loss of treatment response over time. “Psoriasis can be a devastating disease for both the body and the soul with an impact on personal life more than other chronic diseases,” says Valeria Armor , president Apiafco, the Association of Psoriatic Italian Friends of the Foundation Armor. “But don’t be afraid to face this disease or be satisfied with partial results, because, thanks to the latest advances in scientific research, people today with psoriasis can consult a dermatologist and ask to identify the pathway of care is most suitable, and to live free from the disease. We hope that the different Italian regions allow a rapid access to this new treatment.”
“The Republic will fight always in defense of the freedom of information, to its readers and to all those who have at heart the principles of democracy and civil coexistence”
Carlo Verdelli SUBSCRIBERS TO REPUBLIC © Reproduction reserved Today on Here is the “perfect storm”: the great of the Earth react in a scattered order, And now it’s up to us Misiani: “Ready to ask more than 7.5 billion in deficit, to help families and businesses,” Matteo Renzi: “Economic aid extended to the whole Italy and supercommissario immediately. Soon the Eu will be” Blessed are the web
the Republic
